Ono Pharmaceutical Co Ltd

Sustainability Report

Report overview

The report describes the company's FY2021 progress toward decarbonization, including 23.6 kt-CO2 of market-basis Scope 1 and 2 emissions and a 17.0% renewable energy utilization rate. Water intake decreased to 219.4 thousand m3, while industrial waste volume was 479.1 tons and the final landfill rate was 0.04%. The report also includes group governance, human rights, employee development, SDG contributions, TCFD analysis, and independently assured sustainability data.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021-2022
Period: 1 April 2021 – 31 March 2022
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status
CDP score

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Scope 2 emissions
Energy consumption
Renewable energy
Water consumption
Waste
Employees
Women on the board
Women in management
Workplace fatalities
Net zero target

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services